Medicines delisting: the PBAC principles

lots of tiny aspirin pills
To guide its decisions on medicines delisting including those available OTC, the Department of Health has published principles set by the Pharmaceutical Benefits Advisory Committee. The delisting principles considered appropriate by the PBAC include: Schedule 2 or 3 OTC medicine; low ex-manufacturer price; products unlikely to be highly reliant on specialist prescribing and management; and,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Paracetamol challenge a hoax, but still dangerous
Next UK pharmacy services stymied by GPs